Showing results (31-40 of 145) with videos related to
Sort By:
Pageof 15
Molecular and Clinical Oncology|January 21, 2017
Long-term disease stabilization following treatment with erlotinib in heavily pretreated patients with wild-type epidermal growth factor receptor non-small-cell lung carcinoma: Two case reportsMinas Sakellakis, Angelos Koutras, Maria Pittaka, et al.Pharmaceutical Biology|November 7, 2013
The combination of antitumor drugs, exemestane and erlotinib, induced resistance mechanism in H358 and A549 non-small cell lung cancer (NSCLC) cell linesIsmini Kritikou, Efstathia Giannopoulou, Angelos K Koutras, et al.Cancer Genomics & Proteomics|February 4, 2011
Ionizing radiation affects epidermal growth factor receptor signalling and metalloproteinase secretion in glioma cellsMaria Martinou, Efstathia Giannopoulou, Georgia Malatara, et al.Journal of Breast Cancer|October 17, 2015
Early-Stage Breast Cancer in the Elderly: Confronting an Old Clinical ProblemFotinos-Ioannis D Dimitrakopoulos, Anastasia Kottorou, Anna G Antonacopoulou, et al.Journal of Neurology|November 15, 2005
Paclitaxel plus carboplatin-induced peripheral neuropathy. A prospective clinical and electrophysiological study in patients suffering from solid malignanciesAndreas A Argyriou, Panagiotis Polychronopoulos, Gregoris Iconomou, et al.Education for Health (Abingdon, England)|March 15, 2006
Medical students' views of undergraduate Oncology education: A comparative studyMihalis V Karamouzis, Amalia A Ifanti, Gregoris Iconomou, et al.International Journal of Cancer|February 6, 2003
Letrozole as a potent inhibitor of cell proliferation and expression of metalloproteinases (MMP-2 and MMP-9) by human epithelial breast cancer cellsTheoni N Mitropoulou, George N Tzanakakis, Dimitris Kletsas, et al.Investigational New Drugs|July 16, 2009
An in vitro study, evaluating the effect of sunitinib and/or lapatinib on two glioma cell linesEfstathia Giannopoulou, Konstantinos Dimitropoulos, Andreas A Argyriou, et al.Psycho-Oncology|August 15, 2008
Religiosity and its relation to quality of life in Christian Orthodox cancer patients undergoing chemotherapyKonstantinos Assimakopoulos, Katerina Karaivazoglou, Amalia A Ifanti, et al.Critical Reviews in Oncology/Hematology|June 2, 2009
The upgraded role of HER3 and HER4 receptors in breast cancerAngelos K Koutras, George Fountzilas, Konstantine T Kalogeras, et al.Pageof 15